Alison F. Munro

3.0k citations
54 papers · 2.2k indexed · h-index 26
Topics
HER2/EGFR in Cancer Research (15 papers)Breast Cancer Treatment Studies (8 papers)Cancer-related Molecular Pathways (5 papers)

In The Last Decade

Alison F. Munro

54 papers receiving 2.1k citations

Peers

Alison F. Munro
Comparison fields: 5 of 119
  • Oncology 855
  • Molecular Biology 850
  • Cancer Research 557
  • Pulmonary and Respiratory Medicine 285
  • Surgery 258
Replace Shingo Tsuji with:
Shingo Tsuji Japan
John R. Hawse United States
Hua Guo United States
José Palacios Spain
Denise J. Spring United States
Keren Paz United States
Heike Döppler United States
Shixia Huang United States
Khalil Helou Sweden
Lucia Magnelli Italy
Alison F. Munro relative to Shingo Tsuji Japan Shingo Tsuji's profile →
Citations per field
00.5×1.6×
Shingo Tsuji · 1×
Citations per year

Countries citing papers authored by Alison F. Munro

Since Specialization
Citations

This map shows the geographic impact of Alison F. Munro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison F. Munro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison F. Munro more than expected).

Fields of papers citing papers by Alison F. Munro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison F. Munro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison F. Munro. The network helps show where Alison F. Munro may publish in the future.

Co-authorship network of co-authors of Alison F. Munro

This figure shows the co-authorship network connecting the top 25 collaborators of Alison F. Munro. A scholar is included among the top collaborators of Alison F. Munro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison F. Munro. Alison F. Munro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 6
3 6
4 13
5 16
6 26
7 41
8 3
9 13
10 50
11 16
12 74
13 59
14 67
15 72
16 199
17 50
18 21
19 78
20 44

About Alison F. Munro

Alison F. Munro is a scholar working on Oncology, Cancer Research and Genetics, having authored 54 papers that have together received 2.2k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (8 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Cancer Research (557 citations), Oncology (855 citations) and Molecular Biology (850 citations). Alison F. Munro has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include John M.S. Bartlett, Joanne Edwards, J. Shepherd, C.J. Packard, A R Lorimer, A M Gotto, David Cameron, Jeremy Thomas, Neil O. Carragher and R Mukherjee. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026